Pfizer Inc.’s Ian Read plans to step aside as chief executive after eight years helming one of the world’s biggest drugmakers, handing over the reins to deputy Albert Bourla, as the company seeks to boost sales in a tougher pricing and reimbursement climate for the industry. Effective Jan. 1, Mr. Read will serve as the New York pharmaceutical company’s executive chairman indefinitely. Mr. Bourla will become CEO.

Source: Wall Street Journal October 01, 2018 10:38 UTC